Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis
NA
The objectives of this study were to demonstrate comparable safety and effi...
Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox
N/A
The goal of this study is to learn about the effectiveness and safety of tw...
Status
Not Yet Recruiting
Location
UOC di Dermatologia - IRCCS Policlinico di Sant'Orsola - Università di Bologna
Start Date
2025-05-30
Trial ID
NCT06971341
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP
PHASE1
This is a study to investigate the effect of oral ATL-001 (ciclopirox) in C...